Cannara Biotech Inc. Insider Trading
TSX LOVE
2
All Trades
0
Significant
1
Notable
0
Clusters
0
Repeat
Healthcare
Sector
Drug Manufacturers
Industry
$195.6M
Market Cap
1.55 – 2.05
52 Week Range
52K
Avg. Volume
| Company | Insider | Title | Tr. Date | Fi. Date | Shares | Price | Value | Balance | Increase | Signal |
|---|---|---|---|---|---|---|---|---|---|---|
| Cannara Biotech | Olymbec Investments | 10% Shareholder | 29-Jul-26 | 31-Jul-26 | 23,842,920 | NT | ||||
| Cannara Biotech | Sosiak, Nicholas | CFO | 02-Jun-26 | 08-Jun-26 | 821,715 | MN |
Cannara Biotech Inc. (LOVE): Insider trading △ Insider buy
Volume (thousands)
Related Companies to Explore
Company Info
Cannara Biotech Inc. is a Canadian company that operates in the indoor cultivation, processing, and sale of cannabis and cannabis-derivative products. The company runs two business segments: cannabis operations and real estate operations. Its cannabis products are sold under three brand names — TRIBAL, nugz, and ORCHID CBD — and are distributed through wholesalers and online merchandisers. Cannara Biotech was incorporated in 2017 and is headquartered in Saint-Laurent, Canada. It is classified within the healthcare sector, under the drug manufacturers — specialty and generic industry. The company conducts its cannabis activities entirely indoors and limits its operations to the Canadian market. Alongside its core cannabis business, Cannara Biotech also maintains a real estate segment, though cannabis remains its primary focus. The company sells its products both through traditional wholesale channels and through online platforms, serving customers across Canada under its portfolio of distinct consumer-facing brands.
Don’t miss today’s trades
Full access to real-time insider buying data — $8.25/mo, billed annually. Cancel anytime.
